THERANOSTICS 2016*
Chairs: Oliver Neels & Baljinder Singh
Sponsored by:
Beyond wizardry: creating high level evidence for PSMA PET Imaging and Theranostics (#31)
3:30 PM
First in-man study of 68Ga-THP-PSMA PET in patients with primary prostate cancer: initial results (#32)
3:48 PM
Prostate specific membrane antigen targeted radioligand therapy of metastatic castration-resistant prostate cancer using Lu-177 PSMA-617: safety, efficacy and dosimetry in comparison with Lu-177 PSMA I&T (#33)
4:06 PM
Molecular imaging with 64Cu-PSMA PET/CT in Theranostics of prostate cancer (#34)
4:24 PM
Radiolabelling of DOTAMZOL with 68Ga and 44Sc for clinical application (#35)
4:42 PM